AngioSoma Inc. named Ken Stephenson as CEO and president, and appointed him to the board.

Stephenson will focus on bridging the gap between the company's solution, current standard-of-care treatments, and reimbursement by Medicare, Medicaid, and private insurance companies to these medical professionals, according to a news release.

AngioSoma also named Alexanderia Blankenship as COO and executive vice president.